|
Volumn 28, Issue 1, 2008, Pages 33-41
|
Brand and generic medications: Are they interchangeable?
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
CARBAMAZEPINE;
CODEINE SULFATE;
CYCLOSPORIN A;
EYE DROPS;
GENERIC DRUG;
GLICLAZIDE;
GLIMEPIRIDE;
LEVOTHYROXINE;
LEVOTHYROXINE SODIUM;
NADOLOL;
NEW DRUG;
PHENOBARBITAL;
PHENYTOIN;
PROPAFENONE;
THYROTROPIN;
THYROXINE;
UNITHROID;
VERAPAMIL;
WARFARIN;
AREA UNDER THE CURVE;
BIOEQUIVALENCE;
BUDGET;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CHOICE;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG LABELING;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG MONITORING;
DRUG NOMENCLATURE;
DRUG PACKAGING;
DRUG POTENCY;
DRUG PURITY;
DRUG QUALITY;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SAFETY;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE COST;
HEALTH ECONOMICS;
HEART ARRHYTHMIA;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
MAXIMUM PLASMA CONCENTRATION;
MEDLINE;
PHARMACEUTICAL CARE;
PHARMACY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
REVIEW;
SAUDI ARABIA;
SINGLE DRUG DOSE;
THYROTROPIN BLOOD LEVEL;
TIME TO MAXIMUM PLASMA CONCENTRATION;
|
EID: 42949090295
PISSN: 02564947
EISSN: 13199226
Source Type: Journal
DOI: 10.5144/0256-4947.2008.33 Document Type: Review |
Times cited : (29)
|
References (30)
|